Author and year

Country

Intervention (n)

Age

 (mean ± SD)

Sex (M/F)

Abscess/

haemathoma

Biliaryleak

Mortality

Bektas [12] 2014

German

CG: Manual compresion (35)

EG: FS.(35)

CG: 59,8 ± 12,8

EG: 54,7 ± 14,5

CG: 19/16

EG: 20/15

CG: 3 (8,6%)

EG: 0 (0,0%)

CG: 3 (8,6%)

EG: 4 (11,4%)

CG: 1 (2,9%)

EG: 1 (2,9%)

De Boer [13] 2012

Nederland

CG: No FS (154)

EG: Crosseal^® (156)

Median (RIQ)

CG: 61 (51–69)

EG: 62 (53–68)

CG: 76/78

EG: 83/73

CG: 12 (8%)

EG: 10 (6%)

CG: 21 (14%)

EG: 22 (14%)

CG: 2 (1%)

EG: 11 (7%)

Figueras[14] 2007

Spain

CG: No FS (150)

EG: Tissucol^® + Absorbable collagen sponges (150)

CG: 60 ± 11

EG: 62± 11

CG: 46/104

EG: 59/91

CG: 8 (5%)

EG: 9 (6%)

CG: 17 (11%)

EG: 15 (10%)

CG: 2 (1%)

EG: 6 (4%)

Fischer [15] 2011

Germany

CG: Argon beam coagulation (59)

EG: Tachosil^® (60)

CG: 62± 11,7

EG: 60± 12,6

CG: 30/21

EG: 40/27

CG: 1 (1,7%)

EG: 1 (1,7%)

Not available

CG: 4 (6,8%)

EG: 2 (3,3%)

Frilling [16] 2005

Sweden

CG: Argon beam coagulation (62)

EG: Tachosil^® (59)

Not available

Not available

CG: 3 (5%)

EG: 4 (7%)

CG: 2 (3%)

EG: 4 (7%)

CG: 2 (3,2%)

EG: 6 (10,2%)

Noun [17] 1996

France

CG: No FS (44)

EG: Biocol^® (38)

CG: 49± 15

EG: 52± 15

CG: 20/24

EG: 24/14

CG: 9  (20,5%)

EG: 6 (15,8%)

Not available

Not available